{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-025506","form_type":"8-K","ticker":"ETON","cik":"0001710340","company_name":"Eton Pharmaceuticals, Inc.","filed_at":"2026-08-04T11:00:10+00:00","discovered_at":"2026-08-04T11:05:00.386483+00:00","generated_at":"2026-08-04T11:05:04.866431+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Eton Pharmaceuticals appoints Danka Radosavljevic as COO","bullets":["Danka Radosavljevic appointed COO effective July 31, 2026; previously EVP of Operations since 2017.","Annual base salary set at $520,800; discretionary bonus target of 50% of base salary.","Radosavljevic oversaw quality, product development, regulatory, supply chain, and IT in prior role."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-025506","json":"https://secwatch.observer/filing/0001437749-26-025506.json","markdown":"https://secwatch.observer/filing/0001437749-26-025506.md","text":"https://secwatch.observer/filing/0001437749-26-025506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926025506/0001437749-26-025506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926025506/eton20260731_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T11:05:04.866431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}